Researchers



Results 21-40 of 187
Issue DateTitleAuthor(s)TypeМp-cat.
2024Discovery of dual-acting HDAC inhibitors for the treatment of pancreatic cancer by combining drug synergy and molecular modelingĐoković, Nemanja  ; Ilić, Aleksandra  ; Čebzan, Alen  ; Radović, Branko  ; Ružić, Dušan  ; Beljkaš, Milan  ; Đurić, Ana  ; Srdić-Rajić, Tatjana  ; Oljačić, Slavica  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2024Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug DesignBeljkaš, Milan  ; Petković, Miloš  ; Vuletić, Ana  ; Đurić, Ana  ; Santibanez, Juan F.  ; Srdić-Rajić, Tatjana  ; Nikolić, Katarina  ; Oljačić, Slavica  Article
21aM21a
2024Arthrospira platensis Protein Hydrolysates as A Promising Alternatives to Serum in Animal-Cell CultureSibinčić, Nikolina  ; Grozdanic, Nadja  ; Gligorijević, Nikola  ; Veličković, Luka  ; Jovanović, Zorana; Radović, Jelena; Tubić, Lora  ; Stankić, Nevena; Jovanović, Višnja  ; Ivanov, Aleksandar  ;
Srdic-Rajic, Tatjana  ; Nikolić, Milan  ; Stojadinović, Marija  ; Minić, Simeon  ;
Conference Paper
Mp. category will be shown later
2023Discovery of novel HDAC inhibitors for therapy of triple-negative breast cancer – preclinical studyRužić, Dušan  ; Đoković, Nemanja  ; Santibanez, Juan  ; Pavić, Aleksandar  ; Ganesan, A.; Srdić- Rajić, Tatjana  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2023Abstract 2476: Nischarin is a potential druggable target in both epithelial and stromal compartments of pancreatic ductal adenocarcinomaGrahovac, Jelena  ; Živić, Kristina  ; Pavlović, Marijana  ; Ostojić, Marija  ; Đurić, Ana  ; Srdić-Rajić, Tatjana  ; Pavić, Aleksandar  ; Galun, Danijel  Conference Paper
Mp. category will be shown later
2023Nischarin expression may have differing roles in male and female melanoma patientsOstojić, Marija  ; Jevrić, Marko  ; Mitrović-Ajtić, Olivera  ; Živić Kristina  ; Tanić, Miljana  ; Čavić, Milena  ; Srdić-Rajić, Tatjana  ; Grahovac, Jelena  Article
21M21
2023Sulforaphane affects morphological changes and cell viability of colon cancer cells: p53 mutation-dependent effectĐurić, Ana  ; Srdić-Rajić, Tatjana  ; Božić, Dragica; Baralić, Katarina; Pavić, Aleksandar  ; Đukić-Ćosić, DanijelaConference Paper
Mp. category will be shown later
2023Synthesis, characterization, and in vivo evaluation of the anticancer activity of a series of 5- and 6-(halomethyl)-2,2′-bipyridine rhenium tricarbonyl complexesNasiri Sovari, Sara; Kolly, Isabelle; Schindler, Kevin; Djurić, Ana  ; Srdić-Rajić, Tatjana  ; Crochet, Aurelien; Pavić, Aleksandar  ; Zobi, FabioArticle
21aM21a
2023Toxicity testing of D, L-sulforaphane in a zebrafish modelPavić, Aleksandar  ; Radaković, Nataša  ; Srdić-Rajić, Tatjana  ; Božić, Dragica; Baralić, Katarina; Đukić-Ćosić, DanijelaConference Paper
Mp. category will be shown later
2023Towards the multitarget HDAC Inhibitors for the treatment of pancreatic carcinoma by joining the drug synergy predictions and the molecular modelingĐoković, Nemanja  ; Ilić, Aleksandra  ; Čebzan, Alen  ; Radović, Branko  ; Ružić, Dušan  ; Đurić, Ana  ; Srdić-Rajić, Tatjana  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2023Antiproliferative effect of tubastatin A on vemurafenib sensitive and resistant A375 melanoma cellsVuletić, Ana  ; Đinović, Vuk; Miletić, Nevena Tišma  ; Srdić-Rajić, Tatjana  ; Martinović, Mirjačić Katarina  Conference Paper
Mp. category will be shown later
2023Correlating basal gene expression across chemical sensitivity data to screen for novel synergistic interactors of HDAC inhibitors in pancreatic carcinomaNemanja Djokovic  ; Ana Djuric  ; Dusan Ruzic  ; Tatjana Srdic-Rajic  ; Katarina Nikolic  Article
21M21
2022Increased circulating TGF-β1 is associated with impairment in NK cell effector functions in metastatic melanoma patientsMartinovic, Mirjacic Katarina  ; Vuletić, Ana  ; Mališić, Emina  ; Rajić, Tatjana Srdić-  ; Miletić, Nevena Tišma  ; Babović, Nada ; Jurišić, Vladimir  Article
22M22
2022Nischarin agonist rilmenidine inhibits pancreatic ductal adenocarcinoma cell migration and invasionPavlovic, Marijana  ; Ostojic, Marija Z  ; Zivic, Kristina  ; Pavic, Aleksandar B  ; Srdic-Rajic, Tatjana V  ; Grahovac, Jelena S  Conference Paper
Mp. category will be shown later
2022Cationic amphiphilic drugs as potential anticancer therapy for PDACŽivanović, Marija ; Selaković, Milica  ; Selaković, Života  ; Pavić, Aleksandar  ; Grahovac, Jelena  ; Šolaja, Bogdan ; Srdić-Rajić, Tatjana  Conference Paper
Mp. category will be shown later
2022Identification of novel 1-benzhydryl-piperazine derivatives as Histone Deacetylase inhibitors using Fragment-based drug design strategyRužić, Dušan  ; Ellinger, Bernhard; Đoković, Nemanja  ; Santibanez, Juan  ; Ganesan, A.; Pavić, Aleksandar; Srdić Rajić, Tatjana  ; Petković, Miloš  ; Nikolić, Katarina  Other
Mp. category will be shown later
2022Antibody VH domain sequence analysis by a bioinformatics approach based on electronic amino acid properties may help to predict paratop locationSrdić-Rajić, Tatjana  ; Metlaš, RadmilaArticle
22M22
2022Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket DynamicsĐoković, Nemanja  ; Ružić, Dušan  ; Rahnasto-Rilla, Mina; Srdić-Rajić, Tatjana  ; Lahtela-Kakkonen, Maija; Nikolić, Katarina  Article
21aM21a
2022Rilmenidine binds to and inhibits the activity of MDR pumps in pancreatic ductal adenocarcinomaOstojić, Marija  ; Đurić, Ana  ; Srdić-Rajić, Tatjana  ; Dobričić, Vladimir  ; Grahovac, Jelena  Conference Paper
Mp. category will be shown later
2022Rational design and in vitro evaluation of selective inhibitors of cytoplasmic histone deacetylases SIRT2 and HDAC6Ružić, Dušan  ; Đoković, Nemanja  ; Petković, Miloš  ; Gul, Sheraz; Lahtela‐Kakkonen, Maija; Ganesan, A.; Srdić-Rajić, Tatjana  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later